Enzyme activity as an actionable axis for small-molecule precision oncology
Kyohhei Fujita, Mako Kamiya, Shingo Dan, Ryo Tachibana, Minoru Kawatani, Ryosuke Kojima, Rumi Hino, Kimihiko Kobayashi, Shotaro Inoue, Miyuki Tani, Yuko Hirata, Shun Kawashima, Kanami Yamazaki, Yumiko H. Nishimura, Yoshimi Ohashi, , Yasuteru Urano
This paper develops enzyme activity-based prodrugs for precision oncology, showing reduced toxicity and improved efficacy in tumor models.
bioRxiv · Apr 15, 2026 · PreprintCancer Biology